CNSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CNS Pharmaceuticals Inc (CNSP) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive financial performance, no significant news catalysts, and absence of proprietary trading signals suggest that this stock is better suited for monitoring rather than immediate investment.
The MACD is positive and expanding, indicating a bullish momentum. RSI is neutral at 66.12, and moving averages are converging, showing no strong directional trend. The stock is trading near its resistance level (R1: 2.761), suggesting limited short-term upside potential.
MACD indicates bullish momentum. Stock has a 70% chance of gaining 13.06% in the next month based on candlestick pattern analysis.
No recent news or significant trading trends from hedge funds or insiders. Financial performance is weak, with negative net income and declining EPS. No recent congress trading data available.
In Q4 2025, revenue remained at 0 with no YoY growth. Net income improved by 87.50% YoY but remains negative at -$5,955,802. EPS dropped significantly by -90.27% YoY to -9.7, indicating poor profitability. Gross margin is 0, showing no operational profitability.
No analyst rating or price target changes available.
